日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Stem Cell Secretome Treatment Reduces Adiposity and Improves Glucose Handling During Obesity and Weight Loss in Mice.

干细胞分泌组治疗可减少肥胖小鼠的脂肪堆积并改善其在肥胖和减肥过程中的葡萄糖处理能力。

Fennel Zachary J, Kurian Anu S, Bourrant Paul-Emile, Skiles Chad M, Castro Robert J, Yee Elena M, Greilach Scott A, Keirstead Hans S, Nistor Gabriel, Berchtold Nicole C, Lane Thomas E, Drummond Micah J

Effect of immunosuppression on hESC-derived retina organoids in vitro and in vivo.

免疫抑制对体外和体内 hESC 衍生视网膜类器官的影响

Sims Robert, Lin Bin, Xue Yuntian, Fouda Raghda, McLelland Bryce T, Nistor Gabriel, Keirstead Hans S, Browne Andrew W, Seiler Magdalene J

COVID-19 and Lung Cancer Interactions: A Literature Review

COVID-19 与肺癌的相互作用:文献综述

László, Szabolcs-Attila; Ianoși, Edith-Simona; Văsieșiu, Anca-Meda; Szathmáry, Mioara; Ianoși, Maria Beatrice; Rachiș, Delia-Liana; Nistor, Gabriel; Jimborean, Gabriela

Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival

针对新诊断胶质母细胞瘤患者的个体化树突状细胞疫苗的二期临床试验:3年随访及与生存率的相关性

Bota, Daniela A; Piccioni, David E; Duma, Christopher M; Kesari, Santosh; Carrillo, Jose A; LaRocca, Renato V; Aiken, Robert D; Taylor, Thomas H; Abedi, Mehrdad; Robles, Rockelle M; Godding, Krystal; Keirstead, Hans S; Nistor, Gabriel I; Dillman, Robert O

A review of vaccinology and ex vivo antigen-loaded dendritic cells: A different approach to infectious disease vaccines

疫苗学和体外抗原负载树突状细胞综述:传染病疫苗的一种不同方法

Dillman, Robert O; Nistor, Gabriel I; Keirstead, Hans S

Double-Blind Randomized Phase 2 Trial Testing Personal Cancer Vaccines in Patients with Advanced Ovarian Cancer

一项针对晚期卵巢癌患者的双盲随机二期临床试验,旨在测试个性化癌症疫苗

Abaid, Lisa N; Corr, Bradley R; Eskander, Ramez N; Mason, James R; Lopez, Katrina L; Godding, Krystal; Robles, Rockelle M; Keirstead, Hans S; Nistor, Gabriel I; Dillman, Robert O

Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines

负载来自可自我更新的自体肿瘤细胞抗原的自体树突状细胞作为患者特异性治疗性癌症疫苗

Dillman, Robert O; Nistor, Gabriel I; Keirstead, Hans S

Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment

AV-GBM-1(一种靶向肿瘤起始细胞的树突状细胞疫苗)在初诊胶质母细胞瘤患者中的II期研究:安全性和有效性评估

Bota, Daniela A; Taylor, Thomas H; Piccioni, David E; Duma, Christopher M; LaRocca, Renato V; Kesari, Santosh; Carrillo, Jose A; Abedi, Mehrdad; Aiken, Robert D; Hsu, Frank P K; Kong, Xiao-Tang; Hsieh, Candace; Bota, Peter G; Nistor, Gabriel I; Keirstead, Hans S; Dillman, Robert O

A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses

一种可在医疗点制备的个性化新冠病毒树突状细胞疫苗:可行性、安全性和抗原特异性细胞免疫反应

Nistor, Gabriel I; Dillman, Robert O; Robles, Rockelle M; Langford, James L; Poole, Aleksandra J; Sofro, Muchlis A U; Nency, Yetty M; Jonny, Jonny; Yana, Martina L; Karyana, Mahammad; Lestari, Endang S; Triwardhani, Ria; Mujahidah, Mujahidah; Sari, Retty K; Soetojo, Nur A; Wibisono, Djoko; Tjen, Daniel; Ikrar, Taruna; Sarkissian, Gregory; Winarta, Haryono; Putranto, Terawan A; Keirstead, Hans S

Reversal of deficits in aged skeletal muscle during disuse and recovery in response to treatment with a secrotome product derived from partially differentiated human pluripotent stem cells

利用源自部分分化的人类多能干细胞的分泌酶产品进行治疗,可逆转老年骨骼肌在废用和恢复期间的缺陷

Fix, Dennis K; Mahmassani, Ziad S; Petrocelli, Jonathan J; de Hart, Naomi M M P; Ferrara, Patrick J; Painter, Jessie S; Nistor, Gabriel; Lane, Thomas E; Keirstead, Hans S; Drummond, Micah J